TetraLogic Pharmaceuticals Corporation

TLOG · OTC
Analyze with AI
9/30/2016
6/30/2016
3/31/2016
12/31/2015
Operating Activities
Net Income-$9-$7-$11-$14
Dep. & Amort.$0$0$0$0
Deferred Tax$3$0$0$17
Stock-Based Comp.-$0$1$1$1
Change in WC$1-$2$2$0
Other Non-Cash$2$2$2-$13
Operating Cash Flow-$3-$6-$6-$9
Investing Activities
PP&E Inv.$0$0$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0-$5
Inv. Sales/Matur.$0$0$5$14
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$0$5$9
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow$0$0$0$0
Forex Effect$0-$0$0$0
Net Chg. in Cash-$3-$6-$1-$1
Supplemental Information
Beg. Cash$9$15$15$16
End Cash$6$9$15$15
Free Cash Flow-$3-$6-$6-$9
TetraLogic Pharmaceuticals Corporation (TLOG) Financial Statements & Key Stats | AlphaPilot